105 related articles for article (PubMed ID: 17279415)
1. Early clinical impact of iron overload in stem cell transplantation. A prospective study.
Altes A; Remacha AF; Sarda P; Baiget M; Sureda A; Martino R; Briones J; Brunet S; Canals C; Sierra J
Ann Hematol; 2007 Jun; 86(6):443-7. PubMed ID: 17279415
[TBL] [Abstract][Full Text] [Related]
2. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
Altès A; Remacha AF; Sureda A; Martino R; Briones J; Canals C; Brunet S; Sierra J; Gimferrer E
Bone Marrow Transplant; 2002 Jun; 29(12):987-9. PubMed ID: 12098067
[TBL] [Abstract][Full Text] [Related]
3. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
[TBL] [Abstract][Full Text] [Related]
4. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
[TBL] [Abstract][Full Text] [Related]
5. Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients.
Miceli MH; Dong L; Grazziutti ML; Fassas A; Thertulien R; Van Rhee F; Barlogie B; Anaissie EJ
Bone Marrow Transplant; 2006 May; 37(9):857-64. PubMed ID: 16532017
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of iron parameters in patients undergoing allo-SCT.
Bazuaye GN; Buser A; Gerull S; Tichelli A; Stern M
Bone Marrow Transplant; 2012 Jan; 47(1):60-4. PubMed ID: 21399668
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
8. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
[TBL] [Abstract][Full Text] [Related]
9. Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma.
Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1239-44. PubMed ID: 18940678
[TBL] [Abstract][Full Text] [Related]
10. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases.
Auner HW; Zebisch A; Ofner P; Sill H; Linkesch W; Krause R
Ann Hematol; 2005 Aug; 84(8):532-7. PubMed ID: 15809882
[TBL] [Abstract][Full Text] [Related]
12. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.
Kanda J; Mizumoto C; Kawabata H; Ichinohe T; Tsuchida H; Tomosugi N; Matsuo K; Yamashita K; Kondo T; Ishikawa T; Uchiyama T
Biol Blood Marrow Transplant; 2009 Aug; 15(8):956-62. PubMed ID: 19589485
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
16. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients.
Fernández-Ruiz M; López-Medrano F; Andrés A; Morales JM; Lumbreras C; San-Juan R; Polanco N; González E; Aguado JM
Transpl Infect Dis; 2013 Dec; 15(6):600-11. PubMed ID: 24011120
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
[TBL] [Abstract][Full Text] [Related]
19. Factors accounting for high ferritin levels in obesity.
Lecube A; Hernández C; Pelegrí D; Simó R
Int J Obes (Lond); 2008 Nov; 32(11):1665-9. PubMed ID: 18779821
[TBL] [Abstract][Full Text] [Related]
20. Febrile mucositis in haematopoietic SCT recipients.
van der Velden WJ; Blijlevens NM; Feuth T; Donnelly JP
Bone Marrow Transplant; 2009 Jan; 43(1):55-60. PubMed ID: 18762766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
